Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A
MRVI
Market Cap$297.99M
Close$
Share Statistics
| Market cap | $297.99 Million |
|---|---|
| Enterprise Value | $356.35 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.05 |
| Beta | 0.18 |
| Outstanding Shares | 141,812,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.03 |
|---|---|
| PEG | -0.14 |
| Price to Sales | 2.07 |
| Price to Book Ratio | 0.52 |
| Enterprise Value to Revenue | 1.29 |
| Enterprise Value to EBIT | -1.81 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.07 |
| Debt to Equity | 1.17 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Maravai LifeSciences Holdings Inc
3 employeesMaravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and proprietary technologies. Maravai companies are ...